Related references
Note: Only part of the references are listed.Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites
Martin J. McPhillie et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Prenatal therapy with pyrimethamine plus sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial
Laurent Mandelbrot et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)
Congenital toxoplasmosis: An overview of the neurological and ocular manifestations
Khadija Khan et al.
PARASITOLOGY INTERNATIONAL (2018)
Systematic screening and treatment of toxoplasmosis during pregnancy: is the glass half full or half empty?
Jose G. Montoya
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)
Rapid, inexpensive, fingerstick, whole-blood, sensitive, specific, point-of-care test for anti-Toxoplasma antibodies
Joseph Lykins et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis
Kamal El Bissati et al.
EMERGING MICROBES & INFECTIONS (2018)
Evaluation of Three Point-of-Care Tests for Detection of Toxoplasma Immunoglobulin IgG and IgM in the United States: Proof of Concept and Challenges
Carlos A. Gomez et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries
Ian J. Begeman et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving
Andrea-Romana Prusa et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Congenital Toxoplasmosis in France and the United States: One Parasite, Two Diverging Approaches
Francois Peyron et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Protein nanovaccine confers robust immunity against Toxoplasma
Kamal El Bissati et al.
NPJ VACCINES (2017)
Congenital toxoplasmosis in France in 2007: first results from a national surveillance system
I Villena et al.
Eurosurveillance (2017)
Validation of IgG, IgM multiplex plasmonic gold platform in French clinical cohorts for the serodiagnosis and follow-up of Toxoplasma gondii infection
Christelle Pomares et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)
Understanding Toxoplasmosis in the United States Through Large Data Analyses
Joseph Lykins et al.
CLINICAL INFECTIOUS DISEASES (2016)
New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections
Martin McPhillie et al.
SCIENTIFIC REPORTS (2016)
The Austrian Toxoplasmosis Register, 1992-2008
Andrea-Romana Prusa et al.
CLINICAL INFECTIOUS DISEASES (2015)
A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans
Hai-Xia Wei et al.
PLOS ONE (2015)
Congenital toxoplasmosis and prenatal care state programs
Mariza M. Avelino et al.
BMC INFECTIOUS DISEASES (2014)
A Meta Analysis on Risks of Adverse Pregnancy Outcomes in Toxoplasma gondii Infection
Xue-Lan Li et al.
PLOS ONE (2014)
Congenital Toxoplasmosis
James B. McAuley
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2014)
Toxoplasma Seroconversion with Negative or Transient Immunoglobulin M in Pregnant Women: Myth or Reality? A French Multicenter Retrospective Study
H. Fricker-Hidalgo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Efficacy of Rapid Treatment Initiation Following Primary Toxoplasma gondii Infection During Pregnancy
Andrea Hotop et al.
CLINICAL INFECTIOUS DISEASES (2012)
Prematurity and Severity Are Associated With Toxoplasma gondii Alleles (NCCCTS, 1981-2009)
Rima McLeod et al.
CLINICAL INFECTIOUS DISEASES (2012)
Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment
Pablo A. Moncada et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology
J. P. Dubey et al.
PARASITOLOGY (2012)
Severe Congenital Toxoplasmosis in the United States Clinical and Serologic Findings in Untreated Infants
Tudor Rares Olariu et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Maternal Serologic Screening to Prevent Congenital Toxoplasmosis: A Decision-Analytic Economic Model
Eileen Stillwaggon et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Accuracy of Real-Time Polymerase Chain Reaction for Toxoplasma gondii in Amniotic Fluid
Martine Wallon et al.
OBSTETRICS AND GYNECOLOGY (2010)
Prenatal Treatment for Serious Neurological Sequelae of Congenital Toxoplasmosis: An Observational Prospective Cohort Study
Mario Cortina-Borja et al.
PLOS MEDICINE (2010)
Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis
Georgios Pappas et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Management of Toxoplasma gondii infection during pregnancy
Jose G. Montoya et al.
CLINICAL INFECTIOUS DISEASES (2008)
Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis
AP Brézin et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2003)
Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis
L Gras et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2001)
Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii:: retrospective cohort study of 554 mother-child pairs in Lyon, France
RE Gilbert et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2001)